Zobrazeno 1 - 10
of 509
pro vyhledávání: '"J D Kent"'
Publikováno v:
New England Insurance Gazette & Monthly Financial Record; Feb1866, Vol. 4 Issue 10, p239-239, 1/9p
Autor:
J. D. Kent, Douglas C. Wolf, Paul F. Pollack, Ju Li, Stephen B. Hanauer, Paul Rutgeerts, William J. Sandborn, Barry Bittle, Remo Panaccione, Milan Lukas, Richard N. Fedorak, Donald G. MacIntosh
Publikováno v:
Gut. 56:1232-1239
Adalimumab induced clinical remission after four weeks in patients with active Crohn's disease in the CLASSIC I trial.To evaluate long term efficacy and safety of adalimumab maintenance therapy in Crohn's disease in a follow-on randomised controlled
Autor:
J. D. Kent, Glenn M. Eisen, Jay L. Goldstein, Naurang M. Agrawal, William F. Stenson, Kenneth M. Verburg
Publikováno v:
Alimentary Pharmacology & Therapeutics. 20:527-538
Summary Aim : In a predefined analysis, data were pooled from eight blinded, randomized, controlled trials, and separately from three long-term, open-label trials to determine the rate of upper gastrointestinal ulcer complications with the cyclo-oxyg
Autor:
J. D. Kent
Publikováno v:
Proceedings of the Institution of Civil Engineers - Municipal Engineer. 151:265-270
This paper looks at two case studies where winter emergencies are averted by early closure of the road to traffic, and then considers whether these principles are relevant in a wider context. The paper questions whether the public attitude towards tr
Publikováno v:
The Journal of Immunology. 157:4641-4647
The intracellular mechanisms that regulate the function of human neutrophils are not well understood. Receptor-initiated signaling events result in the production of several second messengers (e.g., Ca2+, diacylglycerol, phosphatidic acid, and arachi
Autor:
Sun, Haoyu1,2 (AUTHOR), Cui, Zhiwei1,2 (AUTHOR), Li, Chao3 (AUTHOR), Gao, Zhishuang4 (AUTHOR), Xu, Jun1,2 (AUTHOR), Bian, Yibo5 (AUTHOR), Gu, Tianhao1,2 (AUTHOR), Zhang, Jianan1,2 (AUTHOR), Li, Tengyun1,2 (AUTHOR), Zhou, Qianzheng1,2 (AUTHOR), Yang, Dinghua1,2 (AUTHOR), He, Zhongyuan1,2 (AUTHOR), Li, Bowen1,2 (AUTHOR), Li, Fengyuan1,2 (AUTHOR), Xu, Zekuan1,2 (AUTHOR), Xu, Hao1,2 (AUTHOR) hxu@njmu.edu.cn
Publikováno v:
Advanced Science. 9/11/2024, Vol. 11 Issue 34, p1-17. 17p.
Autor:
Ferreira de Melo, Soryana Gonçalves1, Silva Pereira, Raíssa1, Santana Onnis, Flávio1, Ribeiro Valadares, Nermy2, Mistico Azevedo, Alcinei2, Vieira Pimentel, Guilherme3, Barbosa Evaristo, Anderson4, Carlota Nery, Marcela1 nery.marcela@ufvjm.edu.br
Publikováno v:
Bulgarian Journal of Agricultural Science. 2024, Vol. 30 Issue 5, p856-864. 9p.
Autor:
Maj, Dorota1 (AUTHOR) dorota.maj@urk.edu.pl, Grzesiak, Małgorzata2 (AUTHOR)
Publikováno v:
Animal Science Papers & Reports. 2024, Vol. 42 Issue 3, p271-284. 14p.
Autor:
S, Lichtiger, D G, Binion, D C, Wolf, D H, Present, A G, Bensimon, E, Wu, A P, Yu, A T, Cardoso, J, Chao, P M, Mulani, K G, Lomax, J D, Kent
Publikováno v:
Alimentary pharmacologytherapeutics. 32(10)
Adalimumab induces and maintains remission in adults with Crohn's disease.To evaluate safety, fistula healing, quality of life and work productivity in adalimumab-treated patients who failed infliximab, including primary nonresponders.After a ≥8-we
Autor:
J-F, Colombel, D A, Schwartz, W J, Sandborn, M A, Kamm, G, D'Haens, P, Rutgeerts, R, Enns, R, Panaccione, S, Schreiber, J, Li, J D, Kent, K G, Lomax, P F, Pollack
Publikováno v:
Gut
Gut, 58(7), 940-948. BMJ Publishing Group
Gut, 58(7), 940-948. BMJ Publishing Group
Objective: To evaluate the efficacy of adalimumab in the healing of draining fistulas in patients with active Crohn’s disease (CD). Design: A phase III, multicentre, randomised, double-blind, placebo controlled study with an open-label extension wa